Denali Therapeutics, Inc. (DNLI)
17.99
-0.79
(-4.21%)
USD |
NASDAQ |
Jan 16, 16:00
17.75
-0.24
(-1.33%)
After-Hours: 05:09
Denali Therapeutics Total Liabilities (Quarterly): 129.42M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Enovis Corp. | 2.410B |
| Masimo Corp. | 1.008B |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Twist Bioscience Corp. | 168.90M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.056B |
| Shareholders Equity (Quarterly) | 926.20M |
| Debt to Equity Ratio | 0.0479 |
| Current Ratio | 9.791 |
| Net Debt Paydown Yield | 0.04% |